This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Domanski, M. J. Search for Related Content PubMed PubMed Citation Articles by Domanski, M. J.

Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias

Michael J. Domanski, MD, FACC^*, Sanjeev Sakseena, MD, FACC, FESC^,1, Andrew E. Epstein, MD, FACC, Alfred P. Hallstrom, PhD, Michael A. Brodsky, MD, FACC^||, Soo Kim, MD, FACC^*, Scott Lancaster, MS, Eleanor Schron, RN, MS^* for the AVID Investigators

^* Eastern Heart Institute—Atlantic Health System—Robert Wood Johnson School of Medicine, Newark, New Jersey, USA
University of Alabama at Birmingham, Birmingham, Alabama, USA
University of Washington, Seattle, Washington, USA
University of California, Orange, California, USA
^|| Montefiore Medical Center, Bronx, New York, USA

View larger version (18K): [in a new window]   Figure 1 Survival of patients in different ranges of ejection fraction treated with an AAD or ICD. Cum = cumulative; N = number of patients; Rel-Risk = relative risk.